Abstract
Instead of enormous development in biomedical field, the treatment of severe ailments like tuberculosis, visceral leishmaniasis, systemic fungal infections, HIV and cancer still faces noteworthy confronts like severe toxicities, resistance and patient non-compliance, etc. To overcome these problems interpenetrating polymeric nanomaterials like liposomes, nanoparticles, dendrimers, carbon nanotubes and quantum dots are continuously being explored to improve therapeutic index of available medicine as well as new drug entity. This review exhaustively summarizes the dendrimer-mediated advancements in the drug delivery as well as possible avenues where dendrimers could be exploited to improve the therapeutic effectiveness of currently available treatment strategies. Dendrimers are a new class of interpenetrating polymer network (IPN) with unique properties like well-defined size and structure, versatility, water solubility, multivalency and internal hydrophobic cavities, which rendered these nanostructures an emerging carrier in biomedical and drug delivery applications. Classically, these well-defined nano-architectures have been explored as nanoscaffolds and nano-containers to conjugate and deliver drugs, genes, oligonucleopeptides, imaging agents, siRNA, aptamers, etc. In spite of tremendous research efforts over nearly three decades, the stakeholders are confronted with certain fundamental issues related to dendrimer applications. In this review, we propose to dwell upon the unexplored facets of dendrimer research with possible applications in drug delivery.
IPN: Interpenetrating polymer network
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agashe HB, Dutta TD, Garg M, Jain NK (2006) Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J Pharm Pharmacol 58(11):1491–1498
Agrawal P, Gupta U, Jain NK (2007) Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 28:3349–3359
Ambade AV, Savariar EN, Thayumanavan S (2005) Dendrimeric micelles for controlled drug release and targeted delivery. Mol Pharm 2(4):264–272
Amir RJ, Danieli E, Shabat D (2006) Domino dendrimers. Adv Poly Sci 192:59–94
Amir RJ, Danieli E, Shabat D (2007) Receiver-amplifier, self-immolative dendritic device. Chemistry 13(3):812–821
Asthana A, Chauhan AS, Diwan P, Jain NK (2005) Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS Pharm Sci Tech 6(3):E536–E542
Avaritt BR, Swaan PW (2014) Intracellular Ca2+ release mediates cationic but not anionic poly(amidoamine) (PAMAM) dendrimer-induced tight junction modulation. Pharm Res 31(9):2429–2438
Avci P, Erdem SS, Hamblin MR (2014) Photodynamic therapy: one step ahead with self-assembled nanoparticles. J Biomed Nanotechnol 10(9):1937–1952
Bagre AP, Jain K, Jain NK (2013) Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm 456(1):31–40
Bajwa N, Mehra NK, Jain K, Jain NK (2016a) Pharmaceutical and biomedical applications of quantum dots. Artif Cells Nanomed Biotechnol 44(3):758–768
Bajwa N, Mehra NK, Jain K, Jain NK (2016b) Targeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots. Artif Cells Nanomed Biotechnol 44(7):1774–1782
Barraza LF, Jimenez VA, Alderete JB (2017) Association of methotrexate with native and PEGylated PAMAM-G4 dendrimers: effect of the PEGylation degree on the drug-loading capacity and preferential binding sites. J Phys Chem B 121(1):4–12
Bhadra D, Bhadra S, Jain S, Jain NK (2003) A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm 257:111–124
Bhadra D, Yadav AK, Bhadra S, Jain NK (2005) Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 295:221–233
Bharatwaj B, Dimovski R, Conti DS, da Rocha SR (2014) Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblends. AAPS J 16(3):522–538
Brunetti V, Bouchet LM, Strumia MC (2015) Nanoparticle-cored dendrimers: functional hybrid nanocomposites as a new platform for drug delivery systems. Nanoscale 7:3808–3816
Brunner K, Harder J, Halbach T, Willibald J, Spada F, Gnerlich F, Sparrer K, Beil A, Mockl L, Brauchle C, Conzelmann K, Carell T (2015) Cell-penetrating and neurotargeting dendritic siRNA nanostructures. Angew Chem Int Ed Engl 54(6):1946–1949
Bugno J, Hsu HJ, Hong S (2015) Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting. J Drug Target 23(7–8):642–650
Caminade AM, Laurent R, Majoral JP (2005) Characterization of dendrimers. Adv Drug Del Rev 57:2130–2146
Cason CA, Oehrle SA, Fabré TA, Girten CD, Walters KA, Tomalia DA, Haik KL, Bullen HA (2008) Improved methodology for monitoring poly(amidoamine) dendrimers surface transformations and product quality by ultra performance liquid chromatography. J Nanomat 2008(456082):1–7
Cason CA, Fabré TA, Buhrlage A, Haik KL, Bullen HA (2012) Low-level detection of poly(amidoamine) PAMAM dendrimers using immunoimaging scanning probe microscopy. Int J Anal Chem 2012(341260):1–8
Chandrasekar D, Sistla R, Ahmad FJ, Khar RK, Diwan PV (2007) Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. J Biomed Mater Res A 82(1):92–103
Chanvorachote B, Qiu J, Muangsiri W, Nimmannit U, Kirsch LE (2015) The interaction mechanism between lipopeptide (daptomycin) and polyamidoamine (PAMAM) dendrimers. J Pept Sci. https://doi.org/10.1002/psc.2752
Chen HT, Neerman MF, Parrish AR, Simanek E (2004) Cytotoxicity, haemolysis, and acute in vivo toxicity of dendrimer based on melamine, candidate vehicles for drug delivery. J Am Chem Soc 126(32):10044–10048
Conniot J, Silva JM, Fernandes JG, Silva LC, Gaspar R, Brocchini S, Florindo HF, Barata TS (2014) Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem 2:105
Debnath S, Saloum D, Dolai S, Sun C, Averick S, Raja K, Fata JE (2013) Dendrimer-curcumin conjugate: a water soluble and effective cytotoxic agent against breast cancer cell lines. Anti Cancer Agents Med Chem 13(10):1531–1539
Diaz C, Guzmán J, Jiménez VA, Alderete JB (2018) Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin. Pharm Dev Technol 23(7):689–696
Dobrovolskaia MA (2017) Dendrimers effects on the immune system: insights into toxicity and therapeutic utility. Curr Pharm Des. https://doi.org/10.2174/1381612823666170309151958
Duncan R, Malik N (1996) Dendrimers: biocompatibility and potential for delivery of anticancer agents. Proc Int Symp Control Release Bioact Mater 23:105–106
Dutta T, Jain NK (2007) Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim Biophys Acta 1770(4):681–686
Edagwa BJ, Zhou T, McMillan JM, Liu XM, Gendelman HE (2014) Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies. Curr Med Chem 21(36):4186–4198
El-Sayed M, Kiani MF, Naimark MD, Hikal AH, Ghandehari H (2001) Extravasation of poly(amidoamine) (pamam) dendrimers across microvascular network endothelium. Pharm Res 18:23–28
Estanqueiro M, Amaral MH, Conceicao J, Sousa Lobo JM (2015) Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf B Biointerfaces 126C:631–648
Falanga A, Tarallo R, Carberry T, Galdiero M, Weck M, Galdiero S (2014) Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized Dendrimers. PLoS One 9(11):e112128
Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121–1131
Gajbhiye V, Palanirajan VK, Tekade RK, Jain NK (2009) Dendrimers as therapeutic agents: a systematic review. J Pharm Pharmacol 61(8):989–1003
Ganneau C, Simenel C, Emptas E, Courtiol T, Coic YM, Artaud C, Deriaud E, Bonhomme F, Delepierre M, Leclerc C, Lo-Man R, Bay S (2017) Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate. Org Biomol Chem 15:114–123
Ghalandarlaki N, Alizadeh AM, Ashkani-Esfahani S (2014) Nanotechnology-applied curcumin for different diseases therapy. Biomed Res Int 014(394264):1–23
Gnaim S, Shabat D (2014) Quinone-methide species, a gateway to functional molecular systems: from self-immolative dendrimers to long-wavelength fluorescent dyes. Acc Chem Res 47(10):2970–2984
Harada A, Matsuki R, Ichimura S, Yuba E, Kono K (2013) Intracellular environment-responsive stabilization of polymer vesicles formed from head-tail type polycations composed of a polyamidoaminedendron and poly(L-lysine). Molecules 18(10):12168–12179
He X, Alves CS, Oliveira N, Rodrigues J, Zhu J, Banyai I, Tomas H, Shi X (2015) RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells. Colloids Surf B Biointerfaces 125:82–89
Heyder RS, Zhong Q, Bazito RC, da Rocha SR (2017) Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers. Int J Pharm 520(1–2):181–194
Hinman SS, Ruiz CJ, Cao Y, Ma MC, Tang J, Laurini E, Posocco P, Giorgio S, Pricl S, Peng L, Cheng Q (2017) Mix and match: Coassembly of amphiphilic dendrimers and phospholipids creates robust, modular, and controllable interfaces. ACS Appl Mater Interfaces 11;9(1):1029–1035
Hsu HJ, Bugno J, Lee S, Hong S (2017) Dendrimer-based nanocarriers: a versatile platform for drug delivery. Adv Rev 9(1):e1409
Huang M, Yang CS, Xin Y, Jiang G (2017) Epidermal growth factor receptor-targeted poly(amidoamine)-based dendrimer complexed oncolytic adenovirus: is it safe totally? J Thorac Dis 9(1):E89–E90
Hutnick MA, Ahsanuddin S, Guan L, Lam M, Baron ED, Pokorski JK (2017) PEGylated dendrimers as drug delivery vehicles for the photosensitizer silicon phthalocyanine Pc 4 for candidal infections. Biomacromolecules 18(2):379–385
Ihre H, Padilla De Jesús OL, Fréchet JM (2001) Fast and convenient divergent synthesis of aliphatic ester dendrimers by anhydride coupling. J Am Chem Soc 123(25):5908–5917
Jain K, Jain NK (2012) Dual strategy for treatment of cancer based on development of antiangiogenic carrier for anticancer agent. 2nd international conference on Pharmaceutics & Novel Drug Delivery Systems, Pharm Anal Acta. https://doi.org/10.4172/2153-2435.S1.10
Jain K, Jain NK (2013) Novel therapeutic strategies for treatment of visceral leishmaniasis. Drug Discov Today 18(23–24):1272–1281
Jain K, Jain NK (2014a) Dendrimer: a 21st century nanobiopolymer. Chronicle Pharmabiz. http://www.pharmabiz.com/ArticleDetails.aspx?aid=81282&sid=21
Jain K, Jain NK (2014b) Surface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancer. J Nanosci Nanotechnol 14(7):5075–5087
Jain K, Jain NK (2015) Dendrimers as nanobiopolymers in cancer chemotherapy. Nanobiomedicine, M/s Studium Press LLC, USA
Jain K, Kesharwani P, Gupta U, Jain NK (2010) Dendrimer toxicity: let’s meet the challenge. Int J Pharm 394:122–142
Jain K, Kesharwani P, Gupta U, Jain NK (2012) A review of glycosylated carriers for drug delivery. Biomaterials 33(16):4166–4186
Jain A, Jain K, Mehra NK, Jain NK (2013) Lipoproteins tethered dendrimeric nanoconstructs for effective targeting to cancer cells. J Nanopart Res 15(2003):1–19
Jain K, Gupta U, Jain NK (2014a) Dendronized nanoconjugates of lysine and folate for treatment of cancer. Eur J Pharm Biopharm 87(3):500–509
Jain K, Mehra NK, Jain NK (2014b) Potentials and emerging trends in nanopharmacology. Curr Opin Pharmacol 15C:97–106
Jain K, Mehra NK, Jain NK (2015a) Targeted delivery of anticancer drug with antiangiogenic dendrimers for effective cancer treatment. Nanotechnology: Novel Perspectives and Prospects, McGraw-Hill, USA, pp 838–842
Jain K, Verma AK, Mishra PR, Jain NK (2015b) Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers. Nanomedicine. https://doi.org/10.1016/j.nano.2014.11.008
Jain K, Verma AK, Mishra PR, Jain NK (2015c) Surface engineered dendrimeric nanoconjugates for macrophage targeted delivery of amphotericin B: formulation development, in vitro and in vivo evaluation. Antimicrob Agents Chemother. https://doi.org/10.1128/AAC.04213-14
Jain K, Mehra NK, Jain NK (2015d) Nanotechnology in drug delivery: safety and toxicity issues. Curr Pharm Des 21(29):4252–4261
Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown N, D’Emanuele A (2003) The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263–266
Kaminskas LM, McLeod VM, Ascher DB, Ryan GM, Jones S, Haynes JM, Trevaskis NL, Chan LJ, Sloan EK, Finnin BA, Williamson M, Velkov T, Williams ED, Kelly BD, Owen DJ, Porter CJ (2015) Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in rats. Mol Pharm 12(2):432–443
Kang YO, Lee TS, Park WH (2014) Green synthesis and antimicrobial activity of silver chloride nanoparticles stabilized with chitosan oligomer. J Mater Sci Mater Med 25(12):2629–2638
Kannan S, Kolhe P, Raykova V, Glibatec M, Kannan RM, Lieh-Lai M, Bassett D (2004) Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J Biomater Sci Polymer Ed 15:311–330
Kaur D, Jain K, Mehra NK, Kesharwani P, Jain NK (2016) A review on comparative study of PPI and PAMAM dendrimers. J Nanopart Res 18(6):1–14
Kaur A, Jain K, Mehra NK, Jain NK (2017a) Development and characterization of surface engineered PPI dendrimers for targeted drug delivery. Artif Cells Nanomed Biotechnol 45(3):414–425
Kaur S, Mehra NK, Jain K, Jain NK (2017b) Development and evaluation of targeting ligand-anchored CNTs as prospective targeted drug delivery system. Artif Cells Nanomed Biotechnol 45(2):242–250
Kesharwani P, Jain K, Jain NK (2014) Dendrimer as nanocarrier for drug delivery. Prog Poly Sci 39(2):268–307
Khatri S, Das NG, Das SK (2014) Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells. J Pharm Bioallied Sci 6(4):297–302
Khodadust R, Unsoy G, Gunduz U (2014) Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy. Biomed Pharmacother 68(8):979–987
Kim JH, Yoon HJ, Sim J, Ju SY, Jang WD (2014) The effects of dendrimer size and central metal ions on photosensitizing properties of dendrimer porphyrins. J Drug Target 22(7):610–618
Klajnert B, Bryszewska M (2001) Dendrimers: properties and applications. Acta Biochim Pol 48:199–208
Kojima C, Regino C, Umeda Y, Kobayashi H, Kono K (2010) Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. Int J Pharm 383:293–296
Lee CC, MacKay JA, Frechet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23(12):1517–1526
Lee SH, Choi SH, Kim SH, Park TG (2008) Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release 125:25–32
Li J, Chen L, Liu N, Li S, Hao Y, Zhang X (2015) EGF-coated nano-dendriplexes for tumor-targeted nucleic acid delivery in vivo. Drug Deliv. https://doi.org/10.3109/10717544.2015.1004381
Lin J, Hua W, Zhang Y, Li C, Xue W, Yin J, Liu Z, Qiu X (2015) Effect of poly(amidoamine) dendrimers on the structure and activity of immune molecules. Biochim Biophys Acta 1850(2):419–425
Liu X, Hao W, Lok CN, Wang YC, Zhang R, Wong KK (2014) Dendrimer encapsulation enhances anti-inflammatory efficacy of silver nanoparticles. J Pediatr Surg 49(12):1846–1851
Liu S, Dicker KT, Jia X (2015) Modular and orthogonal synthesis of hybrid polymers and networks. Chem Commun (Camb) 51:5218–5237
Madaan K, Lather V, Pandita D (2014) Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid. Drug Deliv. https://doi.org/10.3109/10717544.2014.910564
Majoros IJ, Williams CR, Tomalia DA, Baker JR Jr (2008) New dendrimers: synthesis and characterization of POPAM – PAMAM hybrid dendrimers. Macromolecules 41(22):8372–8379
Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R (2000) Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125 I-labelled polyamidoamine dendrimers in vivo. J Control Release 65(1–2):133–148
Martinho N, Florindo H, Silva L, Brocchini S, Zloh M, Barata T (2014) Molecular modeling to study dendrimers for biomedical applications. Molecules 19(12):20424–20467
Mehra NK, Verma AK, Mishra PR, Jain NK (2014) The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Biomaterials 35(15):4573–4588
Mehra NK, Jain K, Jain NK (2015a) Novel triazine dendrimer. Encyclopedia of biomedical polymers and polymeric biomaterials. CRC Press. https://doi.org/10.1081/E-EBPP-120049287.
Mehra NK, Jain K, Jain NK (2015b) Pharmaceutical and biomedical applications of surface engineered carbon nanotubes. Drug Discov Today. https://doi.org/10.1016/j.drudis.2015.01.006
Mehra NL, Cai D, Kuo L, Hein T, Palakurthi S (2016) Safety and toxicity of nanomaterials for ocular drug delivery applications. Nanotoxicol 10(7):836–860
Mignani S, Bryszewska M, Klajnert-Maculewicz B, Zablocka M, Majoral JP (2015) Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report. Biomacromolecules 16(1):1–27
Mollazade M, Nejati-Koshki K, Akbarzadeh A, Zarghami N, Nasiri M, Jahanban-Esfahlan R, Alibakhshi A (2013) PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev 14(11):6925–6928
Myc A, Majoros IJ, Thomas TP, Baker JR Jr (2007) Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules 8(1):13–18
Namazi H, Toomari Y, Abbaspour H (2014) Fabrication of triblock ABA type peptide dendrimer based on glutamic acid dimethyl ester and PEG as a potential nano drug delivery agent. Bioimpacts 4(4):175–182
Neerman MF, Zhang W, Parrish AR, Simanek EE (2004) In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery. Int J Pharm 281:129–132
Nguyen TL, Nguyen TH, Nguyen CK, Nguyen DH (2017) Redox and pH responsive poly (amidoamine) dendrimer-heparin conjugates via disulfide linkages for letrozole delivery. BioMed Res Int. Article ID 8589212, 7 pages
Nourse A, Millar DB, Minton AP (2000) Physicochemical characterization of generation 5 polyamidoamine dendrimers. Biopolymers 53(4):316–328
Oddone N, Lecot N, Fernández M, Rodriguez-Haralambides A, Cabral P, Cerecetto H, Benech JC (2016) In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. J Nanobiotechnol 14:45
Padilla De Jesús OL, Ihre HR, Gagne L, Fréchet JM, Szoka FC Jr (2002) Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem 13(3):453–461
Pathak K, Raghuvanshi S (2015) Oral bioavailability: issues and solutions via nanoformulations. Clin Pharmacokinet. https://doi.org/10.1007/s40262-015-0242-x
Peng J, Wu Z, Qi X, Chen Y, Li X (2013) Dendrimers as potential therapeutic tools in HIV inhibition. Molecules 18:7912–7929
Pereira PM, Silva S, Cavaleiro JA, Ribeiro CA, Tome JP, Fernandes R (2014) Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy. PLoS One 9(4):e95529
Prabhu RH, Patravale VB, Joshi MD (2015) Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine 10:1001–1018
Rajananthanan P, Attard GS, Sheikh NA, Morrow WJ (1999) Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice. Vaccine 18(1–2):140–152
Riechers S, Zhong Q, Yin NN, Karsai A, da Rocha SR, Liu GY (2015) High-resolution imaging of polyethylene glycol coated dendrimers via combined atomic force and scanning tunneling microscopy. J Drug Deliv 2015(535683):1–10
Roberts JC, Bhalgat MK, Zera RT (1996) Preliminary biological evaluation of polyaminoamine (PAMAM) starburst dendrimers. J Biomed Mater Res 30:53–65
Sagi A, Weinstain R, Karton N, Shabat D (2008) Self-immolative polymers. J Am Chem Soc 130(16):5434–5435
Sakthivel T, Toth I, Florence AT (1999) Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. Int J Pharm 183:51–55
Sedláková P, Svobodová J, MiksÃk I, Tomás H (2006) Separation of poly(amidoamine) (PAMAM) dendrimer generations by dynamic coating capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci 841(1–2):135–139
Setaro F, Brasch M, Hahn U, Koay MS, Cornelissen JJ, de la Escosura A, Torres T (2015) Generation-dependent templated self-assembly of biohybrid protein nanoparticles around photosensitizer dendrimers. Nano Lett 15(2):1245–1251
Sharma A, Mohanty DK, Desai A, Ali R (2003) A simple polyacrylamide gel electrophoresis procedure for separation of polyamidoamine dendrimers. Electrophoresis 24(16):2733–2739
Shcharbin D, Shcharbina N, Shakhbazau A, Mignani S, Majoral JP, Bryszewska M (2015) Phosphorus-containing nanoparticles: biomedical patents review. Expert Opin Ther Pat. https://doi.org/10.1517/13543776.2015.1010512
Shcharbin D, Shcharbina N, Dzmitruk V, Pedziwiatr-Werbicka E, Ionov M, Mignani S, de la Mata FJ, Gomez R, Munoz-Fernandez MA, Majoral JP, Bryszewska M (2017) Dendrimer-protein interactions versus dendrimer-based nanomedicine. Colloids Surf B Biointerfaces 152:414–422
Shi X, Patri AK, Lesniak W, Islam MT, Zhang C, Baker JR Jr, Balogh LP (2005) Analysis of poly(amidoamine)-succinamic acid dendrimers by slab-gel electrophoresis and capillary zone electrophoresis. Electrophoresis 26(15):2960–2967
Shi X, Bi X, Ganser TR, Hong S, Myc LA, Desai A, Holl MM, Baker JR Jr (2006) HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein. Analyst 131(7):842–848
Singh J, Jain K, Mehra NK, Jain NK (2016) Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers. Artif Cells Nanomed Biotechnol 44(7):1626–1634
Skwarczynski M, Toth I (2014) Recent advances in peptide-based subunit nanovaccines. Nanomedicine (Lond) 9(17):2657–2669
Somani S, Dufès C (2014) Applications of dendrimers for brain delivery and cancer therapy. Nanomedicine (Lond) 9(15):2403–2414
Soni N, Jain K, Gupta U, Jain NK (2015) Controlled delivery of gemcitabine hydrochloride using mannosylated poly (propyleneimine) dendrimers. J Nanopart Res 17(11):458
Sousa-Herves A, Novoa-Carballal R, Riguera R, Fernandez-Megia E (2014) GATG dendrimers and PEGylated block copolymers: from synthesis to bioapplications. AAPS J 16(5):948–961
Souza JG, Dias K, Silva SA, de Rezende LC, Rocha EM, Emery FS, Lopez RF (2015) Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery. J Control Release 200:115–124
Sowinska M, Urbanczyk-Lipkowska Z (2014) Advances in the chemistry of dendrimers. New J Chem 38:2168–2203
Stasko NA, Johnson CB, Schoenfisch MH, Johnson TA, Holmuhamedov EL (2007) Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules 8(12):3853–3859
Stöckigt D, Lohmer G, Belder D (1996) Separation and identification of basic dendrimers using capillary electrophoresis on-line coupled to a sector mass spectrometer. Rapid Commun Mass Spectrom 10(5):521–526
Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) A new class of polymers: starburst dendritic molecules. Polym J 17:117–132
Tsutsumiuchi K, Aoi K, Okada M (2000) Ion complex formation between poly(amido amine) dendrimer HCl salt and poly(l-glutamic acid) sodium salt. Polym J 32:107–112
Tulu M, Aghatabay NM, Senel M, Dizman C, Parali T, Dulger B (2009) Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules. Eur J Med Chem 44(3):1093–1099
Vandamme TF, Brobeck L (2005) Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 20:23–38
Wang L, Xu X, Zhang Y, Zhang Y, Zhu Y, Shi J, Sun Y, Huang Q (2013) Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells. J Mater Sci Mater Med 24(9):2137–2144
Wang H, Huang Q, Chang H, Xiao J, Cheng Y (2016) Stimuli-responsive dendrimers in drug delivery. Biomater Sci 4(3):375–390
Weber N, Ortega P, Clemente MI, Shcharbin D, Bryszewska M, de la Mata FJ, Gómez R, Muñoz-Fernández MA (2008) Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. J Control Release 32(1):55–64
Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang XJ, Rocchi P, Peng L (2015) Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance. Proc Natl Acad Sci U S A 112(10):2978–2983
Wolfbeis OS (2015) An overview of nanoparticles commonly used in fluorescent bioimaging. Chem Soc Rev. https://doi.org/10.1039/C4CS00392F
Wong PT, Choi SK (2015) Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery. Int J Mol Sci 16(1):1772–1790
Wu LP, Ficker M, Christensen JB, Trohopoulos PN, Moghimi SM (2015) Dendrimers in medicine: therapeutic concepts and pharmaceutical challenges. Bioconjug Chem. https://doi.org/10.1021/acs.bioconjchem.5b00031
Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC (2011) Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomedicine 6:2779–2790
Yang H (2016) Targeted nanosystems: advances in targeted dendrimers for cancer therapy. Nanomedicine 12(2):309–316
Yang H, Kao WJ (2006) Dendrimers for pharmaceutical and biomedical applications. J Biomater Sci Polymer Ed 17:3–19
Yellepeddi YK, Ghandehari H (2016) Poly(amido amine) dendrimers in oral delivery. Tissue Barriers 4(2):e1173773 (1–12)
Zhang S, Sun HJ, Hughes AD, Moussodia RO, Bertin A, Chen Y, Pochan DJ, Heiney PA, Klein ML, Percec V (2014) Self-assembly of amphiphilic Janus dendrimers into uniform onion-like dendrimersomes with predictable size and number of bilayers. Proc Natl Acad Sci U S A 111(25):9058–9063
Zhou Z, Lu ZR (2014) Dendritic nanoglobules with polyhedral oligomeric silsesquioxane core and their biomedical applications. Nanomedicine (Lond) 9(15):2387–2401
Zhou Z, Ma X, Murphy CJ, Jin E, Sun Q, Shen Y, Van Kirk EA, Murdoch WJ (2014) Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy. Angew Chem Int Ed Engl 53(41):10949–10955
Conflict of Interest
The authors report no conflict of interest related to manuscript.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jain, K., Mehra, N.K., Jain, V.K., Jain, N.K. (2020). IPN Dendrimers in Drug Delivery. In: Jana, S., Jana, S. (eds) Interpenetrating Polymer Network: Biomedical Applications. Springer, Singapore. https://doi.org/10.1007/978-981-15-0283-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-0283-5_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0282-8
Online ISBN: 978-981-15-0283-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)